loadpatents
Patent applications and USPTO patent grants for Nagao; Rika.The latest application filed is for "compound inhibiting in vivo phosphorus transport and medicine containing the same".
Patent | Date |
---|---|
Compound Inhibiting In Vivo Phosphorus Transport And Medicine Containing The Same App 20120115851 - Eto; Nobuaki ;   et al. | 2012-05-10 |
Compound inhibiting in vivo phosphorous transport and medicine containing the same Grant 8,134,015 - Eto , et al. March 13, 2 | 2012-03-13 |
Calcium receptor active compounds Grant 7,816,408 - Saki , et al. October 19, 2 | 2010-10-19 |
Calcium receptor active compounds App 20090176993 - Sakai; Teruyuki ;   et al. | 2009-07-09 |
Quinoline derivatives and quinazoline derivatives having azolyl group Grant 7,211,587 - Kubo , et al. May 1, 2 | 2007-05-01 |
Compound inhibiting in vivo phosphorous transport and medicine containing the same App 20060217426 - Eto; Nobuaki ;   et al. | 2006-09-28 |
Isoxazole and thiazole compounds and use thereof as medicine Grant 6,964,975 - Ueno , et al. November 15, 2 | 2005-11-15 |
Calcium receptor-active compounds Grant 6,939,895 - Sakai , et al. September 6, 2 | 2005-09-06 |
Quinoline derivatives and quinazoline derivatives having azolyl group Grant 6,821,987 - Kubo , et al. November 23, 2 | 2004-11-23 |
Quinoline derivatives and quinazoline derivatives having azolyl group App 20040229876 - Kubo, Kazuo ;   et al. | 2004-11-18 |
Calcium receptor-active compounds Grant 6,750,255 - Sakai , et al. June 15, 2 | 2004-06-15 |
Calcium receptor active compounds App 20030176485 - Sakai, Teruyuki ;   et al. | 2003-09-18 |
Calcium receptor-active compounds App 20030144526 - Sakai, Teruyuki ;   et al. | 2003-07-31 |
Novel isoxazole and thiazole compounds and use thereof as drugs App 20030114505 - Ueno, Akihiro ;   et al. | 2003-06-19 |
Quinoline derivatives and quinazoline derivatives having azolyl group App 20030087907 - Kubo, Kazuo ;   et al. | 2003-05-08 |
Calcium receptor-active compounds App 20020107406 - Sakai, Teruyuki ;   et al. | 2002-08-08 |
Calcium receptor active compounds Grant 6,362,231 - Sakai , et al. March 26, 2 | 2002-03-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.